Improving Patient Reported Outcome Measures in Catheter Ablation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBarts & The London NHS Trust
About this trial
This study will assess whether more frequent measurement of patient reported outcome measures (PROMs) - specifically health related quality of life (HRQL) - can improve the evaluation of the clinical effectiveness and cost-effectiveness of catheter ablation of ventricular tachycardia (VT) in patients with an Implantable Cardioverter Defibrillator (ICD).
It is designed to have feasibility outcomes which contribute to answering the above.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Validated quality of life questionnaire (EQ-5D & C-CAP)
Treatment groups
70 Participants
are divided into 2 treatment groupsSponsors and collaborators
Barts & The London NHS Trust
Lead sponsor
University College, London
Collaborator
Source ClinicalTrials.gov